Purpose Doublet chemotherapy is more effective than single-agent as first-line treatment of advanced non-small-cell lung cancer (NSCLC).
目的：在进展期非小细胞肺癌(NSCLC)患者一线化疗中，双药联合比但要更有效。
The platinum-based doublet chemotherapy has been considered as the standard first-line treatment for NSCLC with the highest treatment efficacy.
至今，含铂两药化疗仍是非小细胞肺癌群体有效率最高的治疗首选；
The platinum-based doublet chemotherapy has been considered as the standard first-line treatment for NSCLC with the highest treatment efficacy.
至今，含铂两药化疗仍是非小细胞肺癌群体有效率最高的治疗首选；
应用推荐